They were Rb-deficient and Rb-proficient respectively and resembled aggressive human TNBC with the growth of highly proliferative and poorly differentiated mammary carcinomas in allogeneic immune-compromised recipients54 (Supplementary Fig. 10a, b, Supplementary Table 3). This evidence concerns the gene RB1 and breast carcinoma.